Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T20:33:07.462Z.
Calculation as of: 2026-10-06T20:33:07.462Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 45d134847f39473b2f97a1bdf9e3b5a73b5de1aeed529bde146b49b76ed1db6a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
Market Cap
$220.51M
EBITDA Yield
26.78%
TTM Avg
14.06%
3Y Avg
14.49%
5Y Avg
15.75%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Suja Life, Inc. (SUJA) | $243.83M | N/A | N/A | N/A | N/A |
| Limoneira Company (LMNR)vs › | $220.85M | N/A | 1.23% | 7.25% | 5.48% |
| Nature's Sunshine Products, Inc. (NATR)vs › | $220.51M | 26.78% | 14.06% | 14.49% | 15.75% |
| MGP Ingredients, Inc. (MGPI)vs › | $278.81M | N/A | 6.33% | 7.64% | 7.20% |
| Alico, Inc. (ALCO)vs › | $283.82M | N/A | 1.37% | 2.12% | 4.99% |
| CHS Inc. (CHSCM)vs › | $299.10M | 26.50% | N/A | N/A | N/A |
| CHS Inc. (CHSCN)vs › | $300.95M | 26.48% | N/A | N/A | N/A |
| CHS Inc. (CHSCP)vs › | $303.76M | 26.46% | N/A | N/A | N/A |
| CHS Inc. (CHSCL)vs › | $308.64M | 26.43% | N/A | N/A | N/A |
| CHS Inc. (CHSCO)vs › | $309.17M | 26.42% | N/A | N/A | N/A |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
